T. Tritton

发表

Cardiovascular risk profiles: A cross‐sectional study evaluating the generalizability of the glucagon‐like peptide‐1 receptor agonist cardiovascular outcome trials REWIND, LEADER and SUSTAIN‐6 to the real‐world type 2 diabetes population in the United Kingdom

I. Idris, J. Mount, O. Massey, 2021, Diabetes, obesity & metabolism.

Health utilities and quality of life in individuals with tuberous sclerosis complex (TSC) who experience epileptic seizures: A web-based survey

M. Neary, E. Brohan, B. Bennett, 2019, Epilepsy & Behavior.

Characterization of Patients with Chronic Obstructive Pulmonary Disease Initiating Single-Inhaler Long-Acting Muscarinic Antagonist/Long-Acting β2-Agonist Dual Therapy in a Primary Care Setting in England

A. Ismaila, G. Requena, C. Compton, 2022, International journal of chronic obstructive pulmonary disease.

Are patients with COPD more adherent to single-inhaler compared with multiple-inhaler triple therapy in a real-world UK primary care treated population?

A. Ismaila, K. Rothnie, O. Massey, 2021, Airway pharmacology and treatment.

Characterisation of patients with chronic obstructive pulmonary disease initiating single-device inhaled corticosteroids/long-acting β2-agonist dual therapy in a primary care setting in England

A. Ismaila, G. Requena, C. Compton, 2022, BMJ Open Respiratory Research.

Comparative Adherence and Persistence of Single- and Multiple-Inhaler Triple Therapies Among Patients with Chronic Obstructive Pulmonary Disease in an English Real-World Primary Care Setting

N. Snowise, A. Ismaila, Claus F. Vogelmeier, 2022, International journal of chronic obstructive pulmonary disease.

Current treatments used in clinical practice for major depressive disorder and treatment resistant depression in England: A retrospective database study.

C. Kerr, O. Massey, R. Wood, 2021, Journal of Psychiatric Research.

Exploring the Impact of Infusion Frequency in Hemophilia A: Exit Interviews with Patients Participating in BAY 94-9027 Extension Studies (PROTECT VIII)

S. Kessabi, C. Marshall, A. Gater, 2019, The Patient - Patient-Centered Outcomes Research.

Living with Ulcerative Colitis in Japan: Biologic Persistence and Health-Care Resource Use

Timothy W. Smith, J. Cappelleri, M. Dibonaventura, 2021, Inflammatory Intestinal Diseases.

Contemporary economic burden in a real‐world heart failure population with Commercial and Medicare supplemental plans

M. Vaduganathan, H. Bueno, C. Lam, 2021, Clinical cardiology.

Comparative Effectiveness of Umeclidinium/Vilanterol versus Inhaled Corticosteroid/Long-Acting β2-Agonist in Patients with Chronic Obstructive Pulmonary Disease in a Primary Care Setting in England

A. Ismaila, G. Requena, K. Rothnie, 2023, International journal of chronic obstructive pulmonary disease.

Healthcare resource utilisation and costs of hospitalisation and primary care among adults with COVID-19 in England: a population-based cohort study

J. Yang, R. Wood, T. Mugwagwa, 2023, medRxiv.

Treatment Patterns, Healthcare Utilization and Clinical Outcomes of Patients with Chronic Obstructive Pulmonary Disease Initiating Single-Inhaler Long-Acting β2-Agonist/Long-Acting Muscarinic Antagonist Dual Therapy in Primary Care in England

A. Ismaila, G. Requena, C. Compton, 2023, International journal of chronic obstructive pulmonary disease.

Comparison of Rescue Medication Prescriptions in Patients with Chronic Obstructive Pulmonary Disease Receiving Umeclidinium/Vilanterol versus Tiotropium Bromide/Olodaterol in Routine Clinical Practice in England

A. Ismaila, G. Requena, K. Rothnie, 2023, International journal of chronic obstructive pulmonary disease.